Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and efficiency of Propranolol as an initial treatment for pediatric hemangioma.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seoul National University Hospital
NCT07418294 · Hemangioma
NCT01873131 · Hemangioma
NCT04076449 · Cavernous Malformation, Cerebral, Cavernous Angioma, and more
NCT01764529 · Cavernous Angioma, Familial, Cerebral Cavernous Malformations, and more
NCT02625389 · Congenital Hemangioma, Hemangioendothelioma, and more
Seould National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions